Dog DNA tests, cat nutrition, and keeping your pets healthy.
Recent veterinary data indicates a shift in pet ownership trends, with declining spending and a surge in AI adoption among professionals. While no new FDA recalls have been issued this week, industry analysts warn of continued financial challenges for veterinary practices through 2027.
Veterinary AI adoption has surged to 83.7% among U.S. practices, with early adopters reporting six times better business outcomes. Rising pet care costs are reshaping pet ownership economics across generations, while a major acquisition signals consolidation in vet tech. New feline herpesvirus treatments and cancer immunotherapy advances are expanding clinical options for companion animals.
Recent veterinary developments highlight a shift toward year-round preventive care due to extended tick and allergy seasons, alongside significant growth in veterinary telemedicine markets. New research emphasizes the bidirectional relationship between pet nutrition and owner well-being, while FDA advisories remind owners to check for specific dog food recalls.
Recent developments in veterinary science highlight the expansion of cancer immunotherapy for companion animals and new market analyses predicting growth in diagnostic and laboratory animal medicine sectors. Regulatory bodies continue to monitor pet food safety, with recent recalls involving raw diets and wet food products due to bacterial contamination and physical hazards. Industry discussions also focus on workforce models and the integration of advanced diagnostics in clinical practice.
Artificial intelligence is reshaping veterinary medicine with surging investment in diagnostic and remote monitoring technologies, while new FDA pet food recalls highlight ongoing Listeria and Salmonella risks. Veterinary industry data reveals AI tools now support real-time clinical decision-making, even as workforce shortages and mid-level role debates continue to dominate practice management discussions.
Pet prescriptions expanded to CVS Pharmacy nationwide, offering convenient pet medication access. A major veterinary burnout survey launches amid industry staffing challenges. New therapeutic nutrition products expand through retail channels as pet owners seek preventive care solutions.
The veterinary market surges on rising pet ownership and spending, while new clinical breakthroughs in pain management and feline disease treatment offer hope for pet owners. A voluntary pet food recall highlights ongoing safety vigilance in the industry.
New treatments for feline herpesvirus offer easier management for cat owners, while nanoscale diagnostic technology advances veterinary orthopedic care for dogs. Simultaneously, regulatory guidance on anthelmintic effectiveness in cats has been issued, and a landmark partnership between The Farmer's Dog and University of Georgia strengthens veterinary nutrition training across North America.
The veterinary market continues robust growth driven by pet humanization and rising ownership, while new treatments for feline herpesvirus offer owners easier management options. A major pet food recall for potential salmonella contamination underscores ongoing food safety vigilance, and FDA updates highlight evolving pharmaceutical approvals for companion animals.
Pet DNA testing companies face credibility crisis after failing to distinguish human from canine samples, while a new feline herpesvirus treatment offers easier home management for cat owners. The FDA has expanded recalls of raw dog food due to Listeria contamination, and veterinary practice leaders highlight widespread gaps in pet owner knowledge about basic animal care.
This week in veterinary medicine, Elanco launched Befrena™ (tirnovetmab), a new anti-IL-31 monoclonal antibody for canine itch relief, while a global survey of 1,000+ veterinarians across 51 countries revealed surprising gaps between what owners see during vet visits and what actually happens. Meanwhile, the FDA expanded a recall of dog food over Listeria contamination risk, and researchers continue exploring novel monoclonal antibody therapies for diseases including canine parvovirus.
New drugs, new diagnostics, and expanding parasite threats are reshaping small-animal practice this week. A fresh monoclonal antibody injection for canine allergic and atopic dermatitis has officially launched, bringing a major new treatment option to pet owners. Meanwhile, the Purina Institute is leading a global conversation on microbiome science in veterinary medicine, and the AAHA has released updated diabetes management guidelines focused squarely on cats.
New research reveals that millions of "pandemic pets" are now entering midlife, with owners dangerously underestimating the veterinary care window needed to extend healthspan. Meanwhile, the veterinary profession is grappling with frailty assessment as a clinical priority in senior dogs and cats, and the NYT spotlights an accelerating boom in dog longevity treatments with implications for human medicine. On the safety front, FDA's animal drug and recall tracking page logged a new update just days ago.
The AVMA is celebrating National Pet Week 2026 while also updating its raw milk policy to include HPAI risks, and Chewy's acquisition of Modern Animal signals a major shift in veterinary clinic ownership models. On the clinical front, new biologics for dogs address both itching and kennel cough, the FDA has granted emergency authorization for a screwworm treatment spray, and freeze-dried plasma is now available as a canine emergency treatment option.
Canine heartworm disease has expanded into unexpected cooler, drier regions across the U.S., with Texas topping the nation in incidence according to a newly released 2026 American Heartworm Society map. Simultaneously, the Companion Animal Parasite Council's 2026 Pet Parasite Forecast warns of continued geographic expansion of Lyme disease, ehrlichiosis, anaplasmosis, and heartworm risk — calling for year-round prevention. On the clinical front, the FDA has granted emergency use authorization for a spray to prevent and treat screwworm, and researchers are reporting new gene similarities between feline and human cancers.
This week in pet health, veterinary costs continue their upward climb with Canadian pet owners facing 6–8% annual increases, prompting new strategies for financial preparedness. The pet supplement industry is under scrutiny as experts highlight the gap between marketing claims and certified, evidence-backed products. Meanwhile, the FDA's recalls and safety alert pages remain active, and pet owners should stay vigilant about checking for product advisories.
Create custom signals on any topic. AI curates and delivers 24/7.
Create SignalPowered by
